St. Paul, Minn., September 6, 2016 - MD Biosciences announces its attendance at the 13th International Society of Neuroimmunology (ISNI) Congress at the International Convention Center, Jerusalem, Israel – Sept., 26-29, 2016. The ISNI congress is a biennial event which gathers neuroimmunology experts from around the world to present the latest developments and revolutions in the field.
Isaac Levi, Ph.D., Director of MD Biosciences Neurology Laboratories will present recent findings on the assessment of sensory nervous system activity in awakened MOG induced EAE animals, titled “The function of pain associated fibers in MOG induced EAE”.
MD Biosciences has over 20 years of experience in the areas of inflammation, CNS and pain, with an emphasis on the interplay between these systems. To arrange a meeting with MD Biosciences at the event, contact us at [email protected]
About MD Biosciences
MD Biosciences is a discovery and clinical stage pharmaceutical and biotechnological company. Over the course of 25+ years, MD Biosciences has developed a platform based on scientific expertise and knowledge, plus proprietary methodologies. Its platform is based on a deep understanding of inflammatory and immunological pathways, as well as neurological processes leading to disease states and therapeutic approaches. This knowledge is applied to the development of novel therapeutics, diagnostics as well as medical devices. MD Biosciences develops its own pipeline of compounds, develops and provides products for life science research, operates a clinical diagnostic assays laboratory and provides selective services through its contract research arm.